HEADER TRANSFERASE 22-JAN-13 4IV8 TITLE CRYSTAL STRUCTURE OF N-METHYL TRANSFERASE FROM PLASMODIUM KNOWLESI TITLE 2 COMPLEXED WITH S-ADENOSYL METHIONINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE,PUTATIVE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.1.1.103; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM KNOWLESI; SOURCE 3 ORGANISM_TAXID: 5851; SOURCE 4 STRAIN: H; SOURCE 5 GENE: PKH_121150; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS ADOMET_MTASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.LUKK,S.K.NAIR REVDAT 2 20-SEP-23 4IV8 1 REMARK SEQADV LINK REVDAT 1 19-FEB-14 4IV8 0 JRNL AUTH T.LUKK,S.K.NAIR JRNL TITL PHOSPHOETHANOLAMINE N-METHYL TRANSFERASE IS A MALARIAL DRUG JRNL TITL 2 TARGET. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 50979 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2549 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3210 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2950 REMARK 3 BIN FREE R VALUE SET COUNT : 170 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4048 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.86 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.09000 REMARK 3 B22 (A**2) : 0.03000 REMARK 3 B33 (A**2) : 0.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.173 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.160 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.953 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4220 ; 0.007 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5674 ; 1.147 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 492 ; 5.082 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 192 ;34.762 ;25.313 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 818 ;13.938 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;10.740 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 600 ; 0.079 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3100 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4IV8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97856 REMARK 200 MONOCHROMATOR : C(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51018 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.74800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.560 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3UJ7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION WAS AT 15 MG/ML REMARK 280 CONTAINING 20 MM TRIS, 100 MM NACL, 2 MM EDTA AND 5 MM BME, 5 MM REMARK 280 SAM. MOTHER LIQUEUR CONTAINED 0.1 M NA-ACETATE (PH 5.0) AND 20% REMARK 280 PEG 3.350. CRYOPROTECTANT WAS 10% GLYCEROL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 282K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 84.85500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.38000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 84.85500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.38000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -18 REMARK 465 GLY A -17 REMARK 465 SER A -16 REMARK 465 SER A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 SER A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 LEU A -5 REMARK 465 VAL A -4 REMARK 465 PRO A -3 REMARK 465 ARG A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 HIS A 1 REMARK 465 MET A 2 REMARK 465 VAL A 3 REMARK 465 SER A 4 REMARK 465 GLU A 5 REMARK 465 SER A 6 REMARK 465 VAL A 7 REMARK 465 ASP A 8 REMARK 465 ILE A 9 REMARK 465 GLU A 10 REMARK 465 TYR A 11 REMARK 465 LEU A 12 REMARK 465 GLU A 13 REMARK 465 ASN A 14 REMARK 465 ASN A 15 REMARK 465 GLN A 16 REMARK 465 TYR A 17 REMARK 465 SER A 18 REMARK 465 ASP A 19 REMARK 465 GLU A 20 REMARK 465 MET B -18 REMARK 465 GLY B -17 REMARK 465 SER B -16 REMARK 465 SER B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 SER B -8 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 LEU B -5 REMARK 465 VAL B -4 REMARK 465 PRO B -3 REMARK 465 ARG B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 HIS B 1 REMARK 465 MET B 2 REMARK 465 VAL B 3 REMARK 465 SER B 4 REMARK 465 GLU B 5 REMARK 465 SER B 6 REMARK 465 VAL B 7 REMARK 465 ASP B 8 REMARK 465 ILE B 9 REMARK 465 GLU B 10 REMARK 465 TYR B 11 REMARK 465 LEU B 12 REMARK 465 GLU B 13 REMARK 465 ASN B 14 REMARK 465 ASN B 15 REMARK 465 GLN B 16 REMARK 465 TYR B 17 REMARK 465 SER B 18 REMARK 465 ASP B 19 REMARK 465 GLU B 20 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 229 OE2 GLU B 26 2.00 REMARK 500 OE2 GLU A 26 O LEU B 229 2.02 REMARK 500 O ASN B 54 NZ LYS B 56 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 570 O HOH B 570 2535 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 99 87.29 -62.95 REMARK 500 ASP A 161 -104.08 -123.22 REMARK 500 ASN A 195 -5.53 92.34 REMARK 500 LYS B 99 98.73 -63.35 REMARK 500 MET B 107 149.76 -174.60 REMARK 500 ASN B 150 -1.14 79.32 REMARK 500 ASP B 161 -104.93 -121.51 REMARK 500 ASN B 195 1.03 90.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAM A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAM B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4IV0 RELATED DB: PDB DBREF 4IV8 A 2 265 UNP B3L8G9 B3L8G9_PLAKH 1 264 DBREF 4IV8 B 2 265 UNP B3L8G9 B3L8G9_PLAKH 1 264 SEQADV 4IV8 MET A -18 UNP B3L8G9 INITIATING METHIONINE SEQADV 4IV8 GLY A -17 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER A -16 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER A -15 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -14 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -13 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -12 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -11 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -10 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A -9 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER A -8 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER A -7 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 GLY A -6 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 LEU A -5 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 VAL A -4 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 PRO A -3 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 ARG A -2 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 GLY A -1 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER A 0 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS A 1 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 MET B -18 UNP B3L8G9 INITIATING METHIONINE SEQADV 4IV8 GLY B -17 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER B -16 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER B -15 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -14 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -13 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -12 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -11 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -10 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B -9 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER B -8 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER B -7 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 GLY B -6 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 LEU B -5 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 VAL B -4 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 PRO B -3 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 ARG B -2 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 GLY B -1 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 SER B 0 UNP B3L8G9 EXPRESSION TAG SEQADV 4IV8 HIS B 1 UNP B3L8G9 EXPRESSION TAG SEQRES 1 A 284 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 284 LEU VAL PRO ARG GLY SER HIS MET VAL SER GLU SER VAL SEQRES 3 A 284 ASP ILE GLU TYR LEU GLU ASN ASN GLN TYR SER ASP GLU SEQRES 4 A 284 GLY ILE LYS ALA TYR GLU PHE ILE PHE GLY GLU ASP TYR SEQRES 5 A 284 ILE SER SER GLY GLY ILE VAL ALA THR THR LYS ILE LEU SEQRES 6 A 284 SER ASP ILE TYR LEU GLU PRO ASN SER LYS VAL LEU ASP SEQRES 7 A 284 ILE GLY SER GLY LEU GLY GLY GLY CYS LYS TYR ILE ASN SEQRES 8 A 284 GLU LYS TYR ASP ALA HIS VAL TYR GLY VAL ASP ILE CYS SEQRES 9 A 284 GLU LYS MET ILE ALA ILE ALA LYS LEU ARG ASN LYS ASP SEQRES 10 A 284 LYS SER LYS VAL GLU PHE GLU ALA MET ASP ILE LEU LYS SEQRES 11 A 284 LYS ASP PHE PRO GLU CYS THR PHE ASP MET ILE TYR SER SEQRES 12 A 284 ARG ASP ALA ILE LEU HIS LEU PRO TYR ALA ASP LYS LYS SEQRES 13 A 284 LYS LEU PHE GLU LYS CYS TYR LYS TRP LEU LYS PRO ASN SEQRES 14 A 284 GLY ILE LEU LEU ILE THR ASP TYR CYS ALA ASP LYS ILE SEQRES 15 A 284 GLU ASN TRP ASP GLU GLU PHE LYS ALA TYR ILE ASN LYS SEQRES 16 A 284 ARG LYS TYR THR LEU ILE PRO ILE GLN ASP TYR GLY ASP SEQRES 17 A 284 LEU ILE LYS SER CYS ASN PHE GLN ASN VAL GLN ALA LYS SEQRES 18 A 284 ASP ILE SER ASP TYR TRP LEU GLU LEU LEU GLN MET GLU SEQRES 19 A 284 LEU ASN LYS LEU GLU GLU LYS LYS ASP GLU PHE LEU LYS SEQRES 20 A 284 LEU TYR PRO THR ASP GLU TYR ASN SER LEU LYS ASP GLY SEQRES 21 A 284 TRP THR ARG LYS ILE LYS ASP THR LYS ARG HIS LEU GLN SEQRES 22 A 284 LYS TRP GLY TYR PHE LYS ALA GLN LYS MET VAL SEQRES 1 B 284 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 284 LEU VAL PRO ARG GLY SER HIS MET VAL SER GLU SER VAL SEQRES 3 B 284 ASP ILE GLU TYR LEU GLU ASN ASN GLN TYR SER ASP GLU SEQRES 4 B 284 GLY ILE LYS ALA TYR GLU PHE ILE PHE GLY GLU ASP TYR SEQRES 5 B 284 ILE SER SER GLY GLY ILE VAL ALA THR THR LYS ILE LEU SEQRES 6 B 284 SER ASP ILE TYR LEU GLU PRO ASN SER LYS VAL LEU ASP SEQRES 7 B 284 ILE GLY SER GLY LEU GLY GLY GLY CYS LYS TYR ILE ASN SEQRES 8 B 284 GLU LYS TYR ASP ALA HIS VAL TYR GLY VAL ASP ILE CYS SEQRES 9 B 284 GLU LYS MET ILE ALA ILE ALA LYS LEU ARG ASN LYS ASP SEQRES 10 B 284 LYS SER LYS VAL GLU PHE GLU ALA MET ASP ILE LEU LYS SEQRES 11 B 284 LYS ASP PHE PRO GLU CYS THR PHE ASP MET ILE TYR SER SEQRES 12 B 284 ARG ASP ALA ILE LEU HIS LEU PRO TYR ALA ASP LYS LYS SEQRES 13 B 284 LYS LEU PHE GLU LYS CYS TYR LYS TRP LEU LYS PRO ASN SEQRES 14 B 284 GLY ILE LEU LEU ILE THR ASP TYR CYS ALA ASP LYS ILE SEQRES 15 B 284 GLU ASN TRP ASP GLU GLU PHE LYS ALA TYR ILE ASN LYS SEQRES 16 B 284 ARG LYS TYR THR LEU ILE PRO ILE GLN ASP TYR GLY ASP SEQRES 17 B 284 LEU ILE LYS SER CYS ASN PHE GLN ASN VAL GLN ALA LYS SEQRES 18 B 284 ASP ILE SER ASP TYR TRP LEU GLU LEU LEU GLN MET GLU SEQRES 19 B 284 LEU ASN LYS LEU GLU GLU LYS LYS ASP GLU PHE LEU LYS SEQRES 20 B 284 LEU TYR PRO THR ASP GLU TYR ASN SER LEU LYS ASP GLY SEQRES 21 B 284 TRP THR ARG LYS ILE LYS ASP THR LYS ARG HIS LEU GLN SEQRES 22 B 284 LYS TRP GLY TYR PHE LYS ALA GLN LYS MET VAL HET SAM A 301 27 HET BME A 302 4 HET SAM B 301 27 HET BME B 302 4 HETNAM SAM S-ADENOSYLMETHIONINE HETNAM BME BETA-MERCAPTOETHANOL FORMUL 3 SAM 2(C15 H22 N6 O5 S) FORMUL 4 BME 2(C2 H6 O S) FORMUL 7 HOH *363(H2 O) HELIX 1 1 GLY A 21 SER A 35 1 15 HELIX 2 2 GLY A 38 LEU A 46 1 9 HELIX 3 3 GLY A 65 ASP A 76 1 12 HELIX 4 4 CYS A 85 ASN A 96 1 12 HELIX 5 5 ASP A 108 LYS A 112 5 5 HELIX 6 6 ALA A 127 LEU A 131 5 5 HELIX 7 7 PRO A 132 TRP A 146 1 15 HELIX 8 8 LYS A 162 TRP A 166 5 5 HELIX 9 9 ASP A 167 LYS A 178 1 12 HELIX 10 10 PRO A 183 SER A 193 1 11 HELIX 11 11 ILE A 204 LYS A 222 1 19 HELIX 12 12 LYS A 222 TYR A 230 1 9 HELIX 13 13 PRO A 231 ARG A 251 1 21 HELIX 14 14 ILE B 22 SER B 35 1 14 HELIX 15 15 GLY B 38 LEU B 46 1 9 HELIX 16 16 GLY B 65 ASP B 76 1 12 HELIX 17 17 CYS B 85 ASN B 96 1 12 HELIX 18 18 ASP B 108 LYS B 112 5 5 HELIX 19 19 ALA B 127 LEU B 131 5 5 HELIX 20 20 PRO B 132 TRP B 146 1 15 HELIX 21 21 LYS B 162 TRP B 166 5 5 HELIX 22 22 ASP B 167 LYS B 178 1 12 HELIX 23 23 PRO B 183 SER B 193 1 11 HELIX 24 24 ILE B 204 LYS B 222 1 19 HELIX 25 25 LYS B 222 LEU B 227 1 6 HELIX 26 26 PRO B 231 ARG B 251 1 21 SHEET 1 A 7 VAL A 102 ALA A 106 0 SHEET 2 A 7 HIS A 78 ASP A 83 1 N GLY A 81 O GLU A 103 SHEET 3 A 7 LYS A 56 ILE A 60 1 N VAL A 57 O TYR A 80 SHEET 4 A 7 PHE A 119 ARG A 125 1 O TYR A 123 N LEU A 58 SHEET 5 A 7 LEU A 147 ALA A 160 1 O LYS A 148 N PHE A 119 SHEET 6 A 7 GLN A 254 GLN A 262 -1 O GLY A 257 N ASP A 157 SHEET 7 A 7 GLN A 197 ASP A 203 -1 N GLN A 197 O GLN A 262 SHEET 1 B 7 VAL B 102 ALA B 106 0 SHEET 2 B 7 HIS B 78 ASP B 83 1 N GLY B 81 O GLU B 103 SHEET 3 B 7 LYS B 56 ILE B 60 1 N VAL B 57 O TYR B 80 SHEET 4 B 7 PHE B 119 ARG B 125 1 O TYR B 123 N LEU B 58 SHEET 5 B 7 LEU B 147 ALA B 160 1 O LYS B 148 N PHE B 119 SHEET 6 B 7 GLN B 254 GLN B 262 -1 O GLY B 257 N ASP B 157 SHEET 7 B 7 GLN B 197 ASP B 203 -1 N GLN B 200 O LYS B 260 LINK SG CYS A 85 S2 BME A 302 1555 1555 1.98 LINK SG CYS B 85 S2 BME B 302 1555 1555 1.98 CISPEP 1 PRO A 53 ASN A 54 0 -17.27 CISPEP 2 PRO B 53 ASN B 54 0 -9.54 SITE 1 AC1 15 GLY A 61 ASP A 83 ILE A 84 MET A 88 SITE 2 AC1 15 MET A 107 ASP A 108 ILE A 109 ARG A 125 SITE 3 AC1 15 ASP A 126 ALA A 127 HIS A 130 HOH A 407 SITE 4 AC1 15 HOH A 410 HOH A 482 HOH A 518 SITE 1 AC2 2 CYS A 85 LYS A 87 SITE 1 AC3 17 GLY B 61 SER B 62 ASP B 83 ILE B 84 SITE 2 AC3 17 MET B 88 ASP B 108 ILE B 109 ARG B 125 SITE 3 AC3 17 ASP B 126 ALA B 127 HIS B 130 HOH B 417 SITE 4 AC3 17 HOH B 426 HOH B 517 HOH B 528 HOH B 552 SITE 5 AC3 17 HOH B 571 SITE 1 AC4 2 CYS B 85 LYS B 87 CRYST1 169.710 96.760 38.460 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005892 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010335 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026001 0.00000